5/29/2024Bio-Thera and STADA Enter Exclusive Deal for BGolimumab Biosimilar in ...

5/27/2024Review of R&D Spending of A Share-Listed Chinese Pharma Cos in 2023

5/27/2024BioNTech and MediLink Strike A Multi-target TMALIN ADC Technology P...

5/27/2024CStone and Ewopharma Form Strategic Partnership for Sugemalimab in CEE...

5/27/2024Takeda and Degron Enter Multi-Target License Deal to Discover Molecula...

5/24/2024WuXi AppTec Breaks Ground on New Site in Singapore

5/23/2024Bayer to Build Consumer Healthcare Products Supply Center in China

5/23/2024Russia and China to Co-develop New Drugs against Treatment-resistant B...

5/23/2024Takeda and Degron Thera Strike $1.2B Licensing Pact for Molecular Glue...

5/23/2024AstraZeneca Aims to Leverage China's Surge in Innovation to Enhance It...

5/23/2024Asymchem Takes Over Former Pfizer UK Site to Expand Global Footprint

5/22/2024Nona Bio and AstraZeneca Strike Global License Deal for mAb to be Dev...

5/22/2024MaxCyte Signs Platform License Deal with Legend to Accelerate Cell The...

5/20/2024Duoning Bio to Commercialise Single-cell Sorting System for Antibody D...

5/20/2024Sol-Gel and Beimei Pharma Strike Deal to Commercialize TWYNEO in Great...

5/17/2024GVSAP and Biocytogen to Accelerate Biopharma Innovation

5/17/2024Performance Review of A Share-Listed Chinese MedPharm Cos in 2023

5/17/2024Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise

5/17/2024Setback for China-Made PD-1 Inhibitors as FDA Rejects Hengrui and Elev...

5/17/2024Four Investors Inject $400M into Biotech Startup Securing Weight Loss ...

5/15/2024Eisai to Launch Alzheimer's Drug in China

5/15/2024Russia and OncoGenerix to Form Vaccine Partnership

5/9/2024BioNTech Exercises Option to Acquire Exclusive Global Rights to a Prec...

5/9/2024BIO Survey Shows 79% of US biotech Cos Contract with Chinese Firms

5/7/2024Chinese President Promises to Further Open China's Services Sector Inc...

5/7/2024Chinese Biotech Firms Lead Rapid Growth in the ADC Development: Global...

5/7/2024Sanofi Saw 6.2% China Revenue Growth in Q1/2024 on Strong Drug Sales

5/7/2024Sciwind and inno.N Announce Licensing Deal for Ecnoglutide Injection (...

5/7/2024Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2023

5/1/2024BIO Survey Investigates US Biopharma's Dependence on Chinese CDMOs Ami...

Page:20/21 Total number of articles:607: [First][<<] [17] [18] [19] [20] [21] [>>] [End]